Inhibitors of the Formation of Advanced Glycation End Products Based on Pyridoxine Azo Derivatives

A. D. Strelnik,M. N. Agafonova,R. A. Litvinov,R. R. Kazakova,M. A. Belova,Yu. V. Badeev,O. I. Gnezdilov,Yu. G. Shtyrlin,A. A. Spasov,Shtyrlin, Yu. G.
DOI: https://doi.org/10.1134/s107036322315015x
2024-01-11
Russian Journal of General Chemistry
Abstract:Several pyridoxine azo derivatives have been synthesized and their in vitro antiglycation activity has been studied. It has been found that the synthesized compounds are more active in terms of IC 50 than aminoguanidine (by factors of 6–21) and pyridoxamine (by factors of 1.8–5.6). The in vivo study of acute toxicity of the most potent compound has shown their safety (LD 50 > 2000 mg/kg).
chemistry, multidisciplinary
What problem does this paper attempt to address?